Defence Therapeutics Inc. Financial Flexibility Index
Defence Therapeutics Inc. financial flexibility index. Defence Therapeutics Inc. (DTC) has a Financial Flexibility Index of -0.54x as of December 2025. Free cash flow of €-1.40 Million (operating CF €-1.40 Million minus capex €0.00) represents -1% of total liabilities (€2.59 Million). See DTC FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Defence Therapeutics Inc. (2020–2024)
Financial flexibility index of Defence Therapeutics Inc. from 2020 to 2024. Historical Financial Flexibility Index trend for Defence Therapeutics Inc. across 5 annual periods. Explore how well can Defence Therapeutics Inc. service its debt to assess how comfortably operating cash covers total debt obligations.
Defence Therapeutics Inc. Financial Flexibility Index by Year (2020–2024)
Defence Therapeutics Inc. financial flexibility index by year from 2020 to 2024. Year-by-year free cash flow to debt coverage for Defence Therapeutics Inc.. For the full cash flow conversion analysis, see cash efficiency ratio of Defence Therapeutics Inc..
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.01x | €-4.09 Million | €-4.29 Million | €4.06 Million | ▲ +73.9% |
| 2023 | -3.86x | €-7.59 Million | €-7.66 Million | €1.97 Million | ▲ +29.3% |
| 2022 | -5.46x | €-6.04 Million | €-6.04 Million | €1.11 Million | ▲ +70.9% |
| 2021 | -18.73x | €-2.29 Million | €-2.29 Million | €122.26K | ▼ -943.1% |
| 2020 | -1.80x | €-86.81K | €-132.83K | €48.35K | — |